Prostaglandin E2 suppresses hCAP18/LL-37 expression in human macrophages via EP2/EP4: implications for treatment of Mycobacterium tuberculosis infection
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prostaglandin E2 suppresses hCAP18/LL-37 expression in human macrophages via EP2/EP4: implications for treatment of Mycobacterium tuberculosis infection
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume 32, Issue 5, Pages 2827-2840
Publisher
FASEB
Online
2018-01-26
DOI
10.1096/fj.201701308
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bacterial subversion of cAMP signalling inhibits cathelicidin expression, which is required for innate resistance to Mycobacterium tuberculosis
- (2017) Shashank Gupta et al. JOURNAL OF PATHOLOGY
- Antimicrobial peptides as novel anti-tuberculosis therapeutics
- (2016) João P. Silva et al. BIOTECHNOLOGY ADVANCES
- Phenylbutyrate induces LL-37-dependent autophagy and intracellular killing ofMycobacterium tuberculosisin human macrophages
- (2015) Rokeya Sultana Rekha et al. Autophagy
- Prostaglandin E2 and programmed cell death 1 signaling coordinately impair CTL function and survival during chronic viral infection
- (2015) Jonathan H Chen et al. NATURE MEDICINE
- Cathelicidin LL-37 induces time-resolved release of LTB4 and TXA2 by human macrophages and triggers eicosanoid generation in vivo
- (2014) Min Wan et al. FASEB JOURNAL
- Targeted Prostaglandin E2 Inhibition Enhances Antiviral Immunity through Induction of Type I Interferon and Apoptosis in Macrophages
- (2014) François Coulombe et al. IMMUNITY
- Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
- (2014) Katrin D. Mayer-Barber et al. NATURE
- Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2
- (2014) Alastair J O'Brien et al. NATURE MEDICINE
- Little Peptide, Big Effects: The Role of LL-37 in Inflammation and Autoimmune Disease
- (2013) J. M. Kahlenberg et al. JOURNAL OF IMMUNOLOGY
- Ibuprofen Therapy Resulted in Significantly Decreased Tissue Bacillary Loads and Increased Survival in a New Murine Experimental Model of Active Tuberculosis
- (2013) Cristina Vilaplana et al. JOURNAL OF INFECTIOUS DISEASES
- Tuberculosis
- (2013) Alimuddin Zumla et al. NEW ENGLAND JOURNAL OF MEDICINE
- E-type prostanoid receptor 4 (EP4) in disease and therapy
- (2013) Viktoria Konya et al. PHARMACOLOGY & THERAPEUTICS
- PGE2 suppression of innate immunity during mucosal bacterial infection
- (2013) Mallory Agard et al. Frontiers in Cellular and Infection Microbiology
- Prostaglandin E2 restrains macrophage maturation via E prostanoid receptor 2/protein kinase A signaling
- (2012) Z. Zaslona et al. BLOOD
- Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections
- (2012) David M. Tobin et al. CELL
- Prostaglandin E2 Suppresses Antifungal Immunity by Inhibiting Interferon Regulatory Factor 4 Function and Interleukin-17 Expression in T Cells
- (2012) Patricia A. Valdez et al. IMMUNITY
- An Important Role of Prostanoid Receptor EP2 in Host Resistance to Mycobacterium tuberculosis Infection in Mice
- (2012) V. Kaul et al. JOURNAL OF INFECTIOUS DISEASES
- The Cyclic AMP Pathway
- (2012) P. Sassone-Corsi Cold Spring Harbor Perspectives in Biology
- Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1
- (2011) Min Wan et al. FASEB JOURNAL
- International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress
- (2011) D. F. Woodward et al. PHARMACOLOGICAL REVIEWS
- Control of experimental pulmonary tuberculosis depends more on immunostimulatory leukotrienes than on the absence of immunosuppressive prostaglandins
- (2011) C. Peres-Buzalaf et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- The lta4h Locus Modulates Susceptibility to Mycobacterial Infection in Zebrafish and Humans
- (2010) David M. Tobin et al. CELL
- The Vitamin D Receptor: New Paradigms for the Regulation of Gene Expression by 1,25-Dihydroxyvitamin D3
- (2010) J. Wesley Pike et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis
- (2010) Maziar Divangahi et al. NATURE IMMUNOLOGY
- Vitamin D3 Induces Autophagy in Human Monocytes/Macrophages via Cathelicidin
- (2009) Jae-Min Yuk et al. Cell Host & Microbe
- cAMP Stringently Regulates Human Cathelicidin Antimicrobial Peptide Expression in the Mucosal Epithelial Cells by Activating cAMP-response Element-binding Protein, AP-1, and Inducible cAMP Early Repressor
- (2009) Krishnendu Chakraborty et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bacterial exotoxins downregulate cathelicidin (hCAP-18/LL-37) and human β-defensin 1 (HBD-1) expression in the intestinal epithelial cells
- (2008) Krishnendu Chakraborty et al. CELLULAR MICROBIOLOGY
- The role of the multifunctional peptide LL-37 in host defense
- (2008) Ylva Kai-Larsen Frontiers in Bioscience-Landmark
- Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2and LXA4in the induction of macrophage death
- (2008) Minjian Chen et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started